Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug;83(2):237-279.
doi: 10.1016/j.jinf.2021.05.025. Epub 2021 May 28.

Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)

Carlo Pallotto  1 , Pierluigi Blanc  2 , Sara Esperti  3 , Lorenzo Roberto Suardi  4 , Andrea Gabbuti  5 , Francesca Vichi  5 , Lorenzo Mecocci  5 , Anna Degli Esposti  5 , Piera Pierotti  5 , Letizia Attala  5 , Elena Salomoni  5 , Filippo Baragli  5 , Daniela Francisci  6 , Massimo Antonio Di Pietro  5
Affiliations
Comment

Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19)

Carlo Pallotto et al. J Infect. 2021 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Qin L., Huai C., Qingsi Z. Clinical characteristics of COVID-19 patients with complication of cardiac arrhythmia. J Infect. 2020;81(3):e6–e8. - PMC - PubMed
    1. Suardi L.R., Pallotto C., Esperti S., Tazzioli E., Baragli F., Salomoni E. Risk factors for non-invasive/invasive-ventilatory support in patients with COVID-19 pneumonia: a retrospective study within a multidisciplinary approach. Int J Infect Dis. 2020 doi: 10.1016/j.ijid.2020.09.012. S1201-9712(20)30728-1(online ahead of print) - DOI - PMC - PubMed
    1. Pallotto C., Suardi L.R., Esperti S., Tarquini R., Grifoni E., Meini S. Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study. Infect Dis. 2020;52:675–677. (Lond) - PubMed
    1. Bhimraj A., Morgan R.L., Shumaker A.H., Lavergne V., Baden L., Cheng V.C. Infectious diseases society of America guidelines on the treatment and management of patients with COVID-19. Infect Dis Soc Am. 2021 version 4.1.0. Available at . Accessed March 15th 2021. - PMC - PubMed
    1. Kow C.S., Aldeyab M., Hasan S.S. Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19. Eur J Clin Pharmacol. 2021;77(3):435–437. - PMC - PubMed

MeSH terms

LinkOut - more resources